CONGRESS GUIDE
05.09.2016 • Views
Share Embed Flag

CONGRESS GUIDE

ExportFinalProgram_26082016041327

ExportFinalProgram_26082016041327

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
thromboadviser

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

ERS International Congress 2016<br />

INDUSTRY SPONSORED SESSIONS<br />

TUESDAY 06 SEPTEMBER, 2016<br />

17:45<br />

17:55<br />

18:10<br />

18:25<br />

Revolutionizing Chronic bronchitis treatment with the use of Liquid Nitrogen Spray Cryotherapy –<br />

Introducing The RejuvenAir® Metered Cryospray System<br />

Ellen Sheets (Boston, United States of America)<br />

Theory and Evidence Behind RejuvenAir Metered Cryospray - Cryobiology and Treated Airway<br />

Pathology<br />

James Coad (, United States of America)<br />

Results of the Safety and Histological Effects of RejuvenAir Metered Cryospray in the Lung – Safety<br />

and Feasibility Studies<br />

Dirk-Jan Slebos (Groningen, Netherlands)<br />

Effects of Right Lower Lobe Treatment of Symptomatic Chronic Bronchitis Patients with Airflow<br />

Restrictions – Safety and Feasibility Study<br />

Pallav L. Shah (London, United Kingdom)<br />

4742<br />

4743<br />

4744<br />

4745<br />

18:40<br />

The RejuvenAir clinical path and the future potential for clinical practice<br />

Ellen Sheets (Boston, United States of America)<br />

Room ICC Capital Suite 9 Session 677 17:30 - 19:00<br />

Industry evening mini symposium: Targeted Lung Denervation in Obstructive Lung Disease:<br />

Concept to Clinic<br />

Organised by Holaira<br />

Chairs : Felix J.F. Herth (Heidelberg, Germany), Alvar Agusti Garcia-Navarro (Barcelona, Spain)<br />

17:30<br />

Welcome<br />

Felix J.F. Herth (Heidelberg, Germany), Alvar Agusti Garcia-Navarro (Barcelona, Spain)<br />

4746<br />

4747<br />

17:35<br />

17:43<br />

18:00<br />

18:30<br />

Cholinergic Pathways and the limitations of inhaled therapeutics<br />

Reinoud Gosens (Groningen, Netherlands)<br />

Mechanism of Action and the Holaira Lung Denervation System<br />

Martin Mayse (Minneapolis, United States of America)<br />

Targeted Lung Denervation (TLD) in COPD Patients: IPS I/II, AIRFLOW-1, and AIRFLOW-2 Trials<br />

Arschang Valipour (WIEN, Austria)<br />

New TLD Indication: Asthma RELIEF-1 Study<br />

Felix J.F. Herth (Heidelberg, Germany)<br />

4748<br />

4749<br />

4750<br />

4751<br />

18:38<br />

Panel Discussion and Q&A<br />

Felix J.F. Herth (Heidelberg, Germany), Alvar Agusti Garcia-Navarro (Barcelona, Spain), Reinoud Gosens<br />

(Groningen, Netherlands), Martin Mayse (Minneapolis, United States of America), Arschang Valipour<br />

(WIEN, Austria)<br />

Room ICC Capital Suite<br />

2+3<br />

Industry evening expert forum: Optimizing patient care in PAH<br />

Organised by Merck & Co, Inc.<br />

Chairs : H. Ardeschir Ghofrani (Giessen, Germany)<br />

4752<br />

Session 678 17:30 - 19:00<br />

17:30<br />

17:35<br />

17:50<br />

18:05<br />

18:20<br />

Welcome and introduction<br />

H. Ardeschir Ghofrani (Giessen, Germany)<br />

Improving patient care: How different mechanistic approaches impact treatment outcomes<br />

Sean Gaine (Dublin, Ireland)<br />

Optimizing patient care with various treatment agents<br />

Marius M. Hoeper (Hannover, Germany)<br />

Assessing real world patient outcomes<br />

Gérald Simonneau (Le Kremlin-Bicêtre, France)<br />

A challenging clinical case to improve patient care<br />

Horst Olschewski (GRAZ, Austria)<br />

4753<br />

4754<br />

4755<br />

4756<br />

4757<br />

19 26.08.2016

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!